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570 Letters to the Editor August 2013highlighting the utility of endovascular aneurysm repair in this
frail group and the importance of careful patient selection for
open repair in patients with any degree of COPD. Furthermore,
Cox proportional hazards analysis not only conﬁrmed oxygen
dependence was associated with diminished 5-year survival,
but also medically managed COPD, again emphasizing the
ongoing challenge of selecting patients with COPD for aneu-
rysm repair.David H. Stone, MD
Brian W. Nolan, MD, MS
Dartmouth-Hitchcock Medical Center
Lebanon, NH
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Regarding “The impact of endograft type on
inﬂammatory response after endovascular treatment of
abdominal aortic aneurysm”
We read with great interest the paper recently published by
Moulakakis et al.1 In this prospective study, the authors evaluated
the impact of the endograft type on the inﬂammatory response
and concluded that the postimplantation syndrome (PIS) was
not associated with perioperative adverse clinical events showing
a benign course. However, the effect of the syndrome on the
outcome of the patients remains almost unknown. In fact, in
most cases, PIS is generally “well-tolerated,” but in some patients,
it may lead to severe complications, including cardiovascular
events, renal function impairment, and multisystem organ failure
during the postoperative period.2 In a previous publication from
our team, ﬁve patients out of 148 who underwent an endovascu-
lar repair for an abdominal aortic aneurysm manifested a vigorous
inﬂammatory response several days after discharge that led to
readmission; all these patients developed PIS after the procedure.2
In another publication, we reported preliminary data and we
described two patients out of 14 who developed PIS and experi-
enced a nonfatal myocardial infarction on the ﬁrst postoperative
day.3 It is also not uncommon for patients suffering from PIS
to present with symptoms like fatigue and elevated body temper-
ature, sometimes even weeks after the procedure.2,4 This discrep-
ancy regarding the impact of PIS on patients’ outcome compared
with the data reported by Moulakakis et al could be explained by
looking into the methodology of the present study.1 Speciﬁcally,
the postoperative morbidity was not accordingly deﬁned, and
there is a vague statement in the results section that there was
no postoperative increase in cardiac troponin levels. Conse-
quently, a major concern would be whether troponin levels
were the sole criterion for cardiovascular morbidity. But again,
the time intervals of measurements and deﬁnitions are missing,
as well as a detailed description regarding the duration of hospi-
talization, monitoring, and follow-up of the patients during the
ﬁrst month.
In our opinion, the most important reason for the different
conclusions drawn from several studies involving PIS so far is the
lack of a widely accepted deﬁnition. For example, some authors
describe PIS as the presence of leukocytosis and elevated C-reac-
tive protein,4 whereas others deﬁne PIS as the presence of fever
and leukocytosis with different cut-off values.1 Since we have
been studying PIS prospectively and systematically for several
years, we have already proposed a deﬁnition of the syndrome
according to the systemic inﬂammatory response syndrome.2,3
This deﬁnition seems to be more reasonable because there is
evidence supporting a systemic inﬂammatory response induced
by the implantation of the endoprosthesis.2,5 In fact, PIS fulﬁlls
at least two of the systemic inﬂammatory response syndrome
criteria (ie, fever and leukocytosis).6 Therefore, we propose the
deﬁnition of PIS as the presence of fever (persisting bodytemperature >38C) and leukocytosis (white blood cell count
>12,000/mL), despite antibiotic therapy and negative blood
culture results.3,6 We believe that this may represent the best
way to compare variables related to the syndrome among different
studies and to evaluate its clinical signiﬁcance. Nonetheless, close
surveillance of patients developing an excessive inﬂammation
response postoperatively is mandatory and may favorably affect
the outcome.
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Reply
We read with interest the letter by Arnaoutoglou et al report-
ing their concerns about the deﬁnition of the postimplantation
syndrome (PIS) following endovascular aneurysm repair and the
methodology used in our study. The PIS, as manifested clinically,
has gained the interest of vascular surgeons since the early years of
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Volume 58, Number 2 Letters to the Editor 571the application of endovascular aneurysm repair (EVAR). It has
been noticed that the different endografts have various effects on
the inﬂammatory reaction after EVAR.1
Although several deﬁnitions of the PIS have been proposed,
none of them has been widely accepted. Although fatigue,
fever, and leukocytosis present the main features of PIS, elevated
C-reactive protein and coagulation disturbances have also been
described and should be attributed to the syndrome when
present. In our opinion, the syndrome can be adequately
described using a combination of clinical and laboratory data.
In this context, we have closely monitored our patients for clinical
adverse events in the postoperative period.2 White blood cells,
platelets, and temperature were measured at baseline, 24 and
48 hours postoperatively, and afterward if necessary. Postopera-
tive management included measurement of hemoglobin, electro-
lytes, hepatic transaminases, amylase, urea, and creatinine levels.
Physical examination of cardiovascular and respiratory system
with comprehensive monitoring of vital signs was performed
every day postoperatively. In case of chest discomfort, an electro-
cardiogram was performed, and a specialized cardiologist was
called for consultation. Moreover, we measured serum levels of
troponine to recognize subclinical cardiac events. There were
no open conversions and deaths. No renal, pulmonary, or cardiac
complications were recorded.2
The fact that no clinical events were encountered in our
patients is not a consequence of inadequate deﬁnition of postoper-
ative morbidity or lack of monitoring as speculated by Arnaouto-
glou et al. We believe that the clinical impact of the PIS has
been diminished during the last years. This observation, although
still undocumented, probably reﬂects the evolution of the endo-
grafts. Most studies that report on PIS have used ﬁrst or second
generation endografts. Since then, commercially available devices
have evolved, using hydrophilic smaller introducers (low proﬁle)
and have become more ﬂexible and atraumatic. All these changes
lead to less vascular injury during implantation of the endograft,
which is one of the main causes of the PIS.
The inﬂammatory response after EVAR measured in our study
was apparent during the ﬁrst 24 hours and decreased afterward.
Hypothetically, PIS could have occurred in patients who were dis-
charged early, but patients in our study were discharged when
inﬂammation was decreasing and body temperatures had become
normal. The mean hospital stay was 5.4 days, and there were no
readmissions during the ﬁrst month. Consistent with our results,
Voûte et al in a recent study reported that PIS occurred almost
exclusively in the ﬁrst 3 days after woven polyester endograftimplantation and the ﬁrst 2 days after polytetraﬂuoroethylene
endograft implantation.3
We strongly disagree with the use of antibiotic therapy, as sug-
gested by Arnaoutoglou et al, because there is no evidence of
microbial involvement in the development of the syndrome.
Although previous studies have reported that PIS may result in
severe complications and higher readmission rate,4 the inﬂamma-
tory response after EVAR in our study was not associated with
perioperative adverse clinical events. Although we believe that
the clinical impact of the PIS has been diminished during the
last years, we suggest a close surveillance of patients who develop
an excessive inﬂammation response postoperatively.
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